Page last updated: 2024-11-11

1,3-dihydroxy-xanthone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5488193
CHEMBL ID388525
SCHEMBL ID2314333
MeSH IDM0111081

Synonyms (24)

Synonym
1,3-dihydroxyxanthone
CHEMBL388525
AKOS004938955
1,3-dihydroxyxanthen-9-one
9h-xanthen-9-one, 1,3-dihydroxy-
3875-68-1
1,3-dihydroxy-xanthone
9h-xanthen-9-one,1,3-dihydroxy-
GTHOERCJZSJGHB-UHFFFAOYSA-N
STL466245
1,3-dihydroxy-9h-xanthen-9-one
SCHEMBL2314333
HMS3468P10
DTXSID00192030
bdbm174832
us9114126, mb1
NS-02897
CS-0181818
mfcd00800670
D5344
T70866
6,8-dihydroxyxanthone
XD161541
EN300-186368
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 2-alphaHomo sapiens (human)IC50 (µMol)100.00000.48004.35649.9400AID1464403
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
hematopoietic progenitor cell differentiationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-alphaHomo sapiens (human)
DNA ligationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA damage responseDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome segregationDNA topoisomerase 2-alphaHomo sapiens (human)
female meiotic nuclear divisionDNA topoisomerase 2-alphaHomo sapiens (human)
apoptotic chromosome condensationDNA topoisomerase 2-alphaHomo sapiens (human)
embryonic cleavageDNA topoisomerase 2-alphaHomo sapiens (human)
regulation of circadian rhythmDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of apoptotic processDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDNA topoisomerase 2-alphaHomo sapiens (human)
rhythmic processDNA topoisomerase 2-alphaHomo sapiens (human)
negative regulation of DNA duplex unwindingDNA topoisomerase 2-alphaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-alphaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
magnesium ion bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
RNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-alphaHomo sapiens (human)
protein kinase C bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP-dependent activity, acting on DNADNA topoisomerase 2-alphaHomo sapiens (human)
DNA binding, bendingDNA topoisomerase 2-alphaHomo sapiens (human)
protein homodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
ubiquitin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein heterodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
centrioleDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome, centromeric regionDNA topoisomerase 2-alphaHomo sapiens (human)
condensed chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
male germ cell nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
cytoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA topoisomerase 2-alphaHomo sapiens (human)
protein-containing complexDNA topoisomerase 2-alphaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (46)

Assay IDTitleYearJournalArticle
AID1357472Growth inhibition of human HepG2 cells after 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.
AID289303Growth inhibition of human SF268 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
AID1464407Inhibition of recombinant human topoisomerase-2alpha expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as enzyme-mediated supercoiled pBR322 cleavable complex formation up to 10 uM in presence of CaCl2 by ethidiu2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1496399Inhibition of Saccharomyces cerevisiae alpha-glucosidase using PNP glycoside as substrate preincubated for 30 mins followed by substrate addition measured after 60 secs by spectrophotometric method2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Novel oxazolxanthone derivatives as a new type of α-glucosidase inhibitor: synthesis, activities, inhibitory modes and synergetic effect.
AID1357474Growth inhibition of human MCF7 cells after 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.
AID657726Antibacterial activity against Moraxella catarrhalis ATCC 23246 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID361498Inhibition of yeast alpha glucosidase in phosphate buffer after 0.5 hrs by spectrophotometry2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
AID1597635Induction of glucose uptake in human HepG2 cells at 0.625 to 2.5 uM incubated for 24 hrs in low glucose medium2019European journal of medicinal chemistry, Sep-01, Volume: 177Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
AID1464404Ratio of IC50 for recombinant human topoisomerase-2alpha expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as enzyme-mediated decatenation of kinetoplast DNA to IC50 for recombinant human topoisomerase-2alpha cat2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1478622Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
AID1464405Inhibition of recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation at 10 uM in presence of spermine by ethi2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1520336Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2019European journal of medicinal chemistry, Mar-15, Volume: 166All that glitters is not gold: Panning cytotoxic natural products and derivatives with a fused tricyclic backbone by the estimation of their leadlikeness for cancer treatment.
AID661918Antiviral activity against Influenza A virus PR/8/34 H1N1 infected in dog MDCK cells assessed as reduction in virus-induced cytopathic effect at 5 ug/mL2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
AID287846Inhibition of yeast alpha glucosidase at pH 6.82007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
Synthesis of xanthone derivatives with extended pi-systems as alpha-glucosidase inhibitors: insight into the probable binding mode.
AID1464406Inhibition of recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation at 10 uM in presence of spermidine by et2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1464409Inhibition of 3 nM recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation at 10 uM after 4 mins by ethidium b2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1478625Antiproliferative activity against human K562 cells after 48 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
AID1474808Antibacterial activity against Staphylococcus aureus NBRC 100910 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID615825Inhibition of yeast alpha-glucosidase using PNP glycoside as substrate after 30 mins by spectrophotometry2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Toward potent α-glucosidase inhibitors based on xanthones: a closer look into the structure-activity correlations.
AID1478626Antiproliferative activity against human COLO320 cells after 48 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
AID657725Antibacterial activity against Streptococcus pyogenes ATCC 700294 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID1474810Antibacterial activity against Klebsiella pneumoniae NBRC 14940 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID657723Antibacterial activity against Staphylococcus aureus ATCC 29213 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID1478623Antiproliferative activity against human MCF7 cells after 48 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
AID657727Antibacterial activity against Haemophilus influenzae ATCC 49247 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID289301Growth inhibition of human MCF7 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
AID1464400Poison activity at recombinant human topoisomerase-2alpha expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as enzyme-mediated supercoiled pBR322 cleavable complex formation at 2.5 to 100 uM after 6 mins by ethid2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID1597640Cytotoxicity against human L02 cells assessed as effect on cell survival at 0.625 to 2.5 uM incubated for 44 hrs by MTT assay2019European journal of medicinal chemistry, Sep-01, Volume: 177Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
AID657729Cytotoxicity against human HepG2 cells assessed as NADH level after overnight incubation by MTS assay2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID661915Inhibition of wild type H1N1 swine influenza virus neuraminidase using 4-MU-NANA as substrate by fluorescence assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
AID1464403Inhibition of 3 nM recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation after 4 mins by ethidium bromide st2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID661914Inhibition of Influenza A virus H9N2 neuraminidase using 4-MU-NANA as substrate by fluorescence assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
AID1275955Inhibition of yeast alpha-glucosidase using PNP glycoside as substrate preincubated for 30 mins followed by substrate addition measured for 60 secs by spectrophotometric analysis2016Bioorganic & medicinal chemistry, Apr-01, Volume: 24, Issue:7
Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents' effect.
AID657728Antibacterial activity against Escherichia coli ATCC 25922 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID1478624Antiproliferative activity against human HepG2 cells after 48 hrs by CCK8 assay2017European journal of medicinal chemistry, Jun-16, Volume: 133Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.
AID1357473Growth inhibition of human MDA-MB-231 cells after 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.
AID1474809Antibacterial activity against Bacillus subtilis NBRC 13719 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID661912Selectivity ratio of IC50 for wild type H1N1 swine influenza virus neuraminidase to IC50 for oseltamivir-resistant H1N1 swine influenza virus neuraminidase H274Y mutant2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
AID661913Inhibition of Influenza A virus H1N1 neuraminidase using 4-MU-NANA as substrate by fluorescence assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
AID289304Growth inhibition of human UACC62 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
AID657730Cytotoxicity against human Jurkat T cells assessed as NADH level after overnight incubation by MTS assay2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID289302Growth inhibition of human NCI-H460 cells2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
AID657724Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 20 to 22 hrs by broth microdilution method2012Bioorganic & medicinal chemistry, May-15, Volume: 20, Issue:10
An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization.
AID1474811Antibacterial activity against Escherichia coli NBRC 102203 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID1464408Inhibition of 150 nM recombinant human topoisomerase-2alpha catalytic activity expressed in Saccharomyces cerevisiae JEL1 harboring topoisomerase1 deletion mutant assessed as reduction in supercoiled pBR322 DNA relaxation at 10 uM after 4 mins by ethidium2017Bioorganic & medicinal chemistry letters, 10-15, Volume: 27, Issue:20
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
AID661916Inhibition of oseltamivir-resistant H1N1 swine influenza virus neuraminidase H274Y mutant using 4-MU-NANA as substrate by fluorescence assay2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's11 (73.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]